Login OPEN ICICI 3-in-1 Account

CORAL LABORATORIES SHARE PRICE

Sector Pharmaceuticals
BSE 524506
474.60
4.85 (1.03 %)
Buy
B
Sell
S
BSE

Overview

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

Day Low

465.00

Day High

474.80

52 Week Low

442.55

52 Week High

859.00

All Time Low

23.30

All Time High

1,190.00

Open

471.00

Close

469.75

Volume

100

Mkt cap (Cr)

169.57

P/E ratio

9.66

P/B ratio

0.79

Div yield

0.00%

6M return

-20.25%

1Y return

-42.04%

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

474.60 1.03%

Current Price

Tech Pointer
  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Coral Laboratories Ltd

Stock PE (TTM)

9.66

Promoter Holding

71.51%

Book Value

596.8852

ROCE

16.98%

ROE

12.76%

Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group. To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company went into public issue in March 94 at a total cost of Rs.2.5 crores. It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004. It started the commercial production at Dehradun Plant in September, 2006.

Coral Laboratories share price as on 05 Dec 2025 is Rs. 474.6. Over the past 6 months, the Coral Laboratories share price has decreased by 20.25% and in the last one year, it has decreased by 42.04%. The 52-week low for Coral Laboratories share price was Rs. 442.55 and 52-week high was Rs. 859.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

524506

INE683E01017

Sep

Coral Laboratories Ltd FAQs

You can buy Coral Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Coral Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Dec 05, 2025 11:30 AM the closing price of Coral Laboratories Ltd was Rs.474.60.

The latest PE ratio of Coral Laboratories Ltd as of Dec 05, 2025 11:30 AM is 9.66

The latest PB ratio of Coral Laboratories Ltd as of Dec 05, 2025 11:30 AM is 0.79

The 52-week high of Coral Laboratories Ltd share price is Rs. 859.00 while the 52-week low is Rs. 442.55

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Dec 05, 2025 11:30 AM, the market cap of Coral Laboratories Ltd stood at Rs. 169.57 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.